3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
3
Unknown
2
Completed
2
Recruiting
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Uterine Cervical Dysplasia
2
Stomach Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Precancerous Conditions
1
Papillomavirus Infections
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Atypical Squamous Cells of the Cervix
1
Anus Neoplasms
1
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
3
epigallocatechin gallate
2
artesunic acid
2
artemisinin
2
Transurethral Resection of Prostate
2
Surveys and Questionnaires
2
Papillomavirus Vaccines
2
Cytological Techniques
2
Colposcopy
2
Cisplatin
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
human papillomavirus vaccine, L1 type 16, 18
1
artenimol
1
Vitamin B 12
1
Vaccination
1
Triage
1
Standing Orders
1
Specimen Handling
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Mass Screening
1
Liquid Biopsy
1
Lacteol
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Folic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Papillomavirus Infections
×
Human Papillomavirus DNA Tests
×
Clear all
NCT07281430
2026-05-13
LMI-001-A-S04
National Cancer Institute (NCI)
Phase NA
Recruiting
500 enrolled